Literature DB >> 17701665

Placental growth hormone is increased in the maternal and fetal serum of patients with preeclampsia.

Pooja Mittal1, Jimmy Espinoza, Sonias Hassan, Juan Pedro Kusanovic, Samuel S Edwin, Jyh Kae Nien, Francesca Gotsch, Nandor Gabor Than, Offer Erez, Shali Mazaki-Tovi, Roberto Romero.   

Abstract

OBJECTIVES: Placental growth hormone (PGH) is a pregnancy-specific protein produced by syncytiotrophoblast and extravillous cytotrophoblast. No other cells have been reported to synthesize PGH Maternal. PGH Serum concentration increases with advancing gestational age, while quickly decreasing after delivery of the placenta. The biological properties of PGH include somatogenic, lactogenic, and lipolytic functions. The purpose of this study was to determine whether the maternal serum concentrations of PGH change in women with preeclampsia (PE), women with PE who deliver a small for gestational age neonate (PE + SGA), and those with SGA alone. STUDY
DESIGN: This cross-sectional study included maternal serum from normal pregnant women (n = 61), patients with severe PE (n = 48), PE + SGA (n = 30), and SGA alone (n = 41). Fetal cord blood from uncomplicated pregnancies (n = 16) and PE (n = 16) was also analyzed. PGH concentrations were measured by ELISA. Non-parametric statistics were used for analysis.
RESULTS: (1) Women with severe PE had a median serum concentration of PGH higher than normal pregnant women (PE: median 23,076 pg/mL (3473-94 256) vs. normal pregnancy: median 12 157 pg/mL (2617-34 016); p < 0.05), pregnant women who delivered an SGA neonate (SGA: median 10 206 pg/mL (1816-34 705); p < 0.05), as well as pregnant patients with PE and SGA (PE + SGA: median 11 027 pg/mL (1232-61 702); p < 0.05). (2) No significant differences were observed in the median maternal serum concentration of PGH among pregnant women with PE and SGA, SGA alone, and normal pregnancy (p > 0.05). (3) Compared to those of the control group, the median umbilical serum concentration of PGH was significantly higher in newborns of preeclamptic women (PE: median 356.1 pg/mL (72.6-20 946), normal pregnancy: median 128.5 pg/mL (21.6-255.9); p < 0.01). (4) PGH was detected in all samples of cord blood.
CONCLUSIONS: (1) PE is associated with higher median concentrations of PGH in both the maternal and fetal circulation compared to normal pregnancy. (2) Patients with PE + SGA had lower maternal serum concentrations of PGH than preeclamptic patients without SGA. (3) Contrary to previous findings, PGH was detectable in the fetal circulation. The observations reported herein are novel and suggest that PGH may play a role in the mechanisms of disease in preeclampsia and fetal growth restriction.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17701665      PMCID: PMC2276338          DOI: 10.1080/14767050701463571

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  74 in total

1.  Relationships between placental GH concentration and maternal smoking, newborn gender, and maternal leptin: possible implications for birth weight.

Authors:  R Coutant; F Boux de Casson; O Douay; E Mathieu; S Rouleau; F Beringue; P Gillard; J M Limal; P Descamps
Journal:  J Clin Endocrinol Metab       Date:  2001-10       Impact factor: 5.958

2.  Human placental growth hormone causes severe insulin resistance in transgenic mice.

Authors:  Linda A Barbour; Jianhua Shao; Liping Qiao; Leslie K Pulawa; Dalan R Jensen; Andrzej Bartke; Maureen Garrity; Boris Draznin; Jacob E Friedman
Journal:  Am J Obstet Gynecol       Date:  2002-03       Impact factor: 8.661

3.  Placental growth hormone and IGF-I in a pregnant woman with Pit-1 deficiency.

Authors:  J Verhaeghe; M Bougoussa; E Van Herck; F de Zegher; G Hennen; A Igout
Journal:  Clin Endocrinol (Oxf)       Date:  2000-11       Impact factor: 3.478

4.  Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor.

Authors:  Jimmy Espinoza; Roberto Romero; Jyh Kae Nien; Ricardo Gomez; Juan Pedro Kusanovic; Luis F Gonçalves; Luis Medina; Sam Edwin; Sonia Hassan; Mario Carstens; Rogelio Gonzalez
Journal:  Am J Obstet Gynecol       Date:  2007-04       Impact factor: 8.661

5.  Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction.

Authors:  Wenzel Wallner; Ruth Sengenberger; Reiner Strick; Pamela L Strissel; Britta Meurer; Matthias W Beckmann; Dietmar Schlembach
Journal:  Clin Sci (Lond)       Date:  2007-01       Impact factor: 6.124

6.  Placental growth hormone (GH), GH-binding protein, and insulin-like growth factor axis in normal, growth-retarded, and diabetic pregnancies: correlations with fetal growth.

Authors:  H D McIntyre; R Serek; D I Crane; T Veveris-Lowe; A Parry; S Johnson; K C Leung; K K Ho; M Bougoussa; G Hennen; A Igout; F Y Chan; D Cowley; A Cotterill; R Barnard
Journal:  J Clin Endocrinol Metab       Date:  2000-03       Impact factor: 5.958

7.  Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome.

Authors:  Yan Zhou; Michael McMaster; Kirstin Woo; Mary Janatpour; Jean Perry; Terhi Karpanen; Kari Alitalo; Caroline Damsky; Susan J Fisher
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

8.  Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia.

Authors:  S C Tidwell; H N Ho; W H Chiu; R J Torry; D S Torry
Journal:  Am J Obstet Gynecol       Date:  2001-05       Impact factor: 8.661

9.  Placental growth hormone and lactogen production by perifused ovine placental explants: regulation by growth hormone-releasing hormone and glucose.

Authors:  M C Lacroix; P Bolifraud; D Durieux; A Pauloin; M Vidaud; G Kann
Journal:  Biol Reprod       Date:  2002-03       Impact factor: 4.285

Review 10.  Human placental growth hormone--a review.

Authors:  M C Lacroix; J Guibourdenche; J L Frendo; F Muller; D Evain-Brion
Journal:  Placenta       Date:  2002-04       Impact factor: 3.481

View more
  15 in total

1.  Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia.

Authors:  Tinnakorn Chaiworapongsa; Roberto Romero; Zeynep Alpay Savasan; Juan Pedro Kusanovic; Giovanna Ogge; Eleazar Soto; Zhong Dong; Adi Tarca; Bhatti Gaurav; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2011-08-09

2.  Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia.

Authors:  Giovanna Ogge; Tinnakorn Chaiworapongsa; Roberto Romero; Youssef Hussein; Juan Pedro Kusanovic; Lami Yeo; Chong Jai Kim; Sonia S Hassan
Journal:  J Perinat Med       Date:  2011-08-17       Impact factor: 1.901

3.  Maternal and neonatal circulating visfatin concentrations in patients with pre-eclampsia and a small-for-gestational age neonate.

Authors:  Shali Mazaki-Tovi; Edi Vaisbuch; Roberto Romero; Juan Pedro Kusanovic; Tinnakorn Chaiworapongsa; Sun Kwon Kim; Chia-Ling Nhan-Chang; Ricardo Gomez; Zeynep Alpay Savasan; Ichchha Madan; Bo Hyun Yoon; Lami Yeo; Pooja Mittal; Giovanna Ogge; Juan M Gonzalez; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2010-10

4.  Could alterations in maternal plasma visfatin concentration participate in the phenotype definition of preeclampsia and SGA?

Authors:  Shali Mazaki-Tovi; Roberto Romero; Sun Kwon Kim; Edi Vaisbuch; Juan Pedro Kusanovic; Offer Erez; Tinnakorn Chaiworapongsa; Francesca Gotsch; Pooja Mittal; Chia-Ling Nhan-Chang; Nandor Gabor Than; Ricardo Gomez; Jyh Kae Nien; Samuel S Edwin; Percy Pacora; Lami Yeo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2010-08

5.  Reversal of gene dysregulation in cultured cytotrophoblasts reveals possible causes of preeclampsia.

Authors:  Yan Zhou; Matthew J Gormley; Nathan M Hunkapiller; Mirhan Kapidzic; Yana Stolyarov; Victoria Feng; Masakazu Nishida; Penelope M Drake; Katherine Bianco; Fei Wang; Michael T McMaster; Susan J Fisher
Journal:  J Clin Invest       Date:  2013-06-24       Impact factor: 14.808

6.  Distinct genomic signatures of adaptation in pre- and postnatal environments during human evolution.

Authors:  Monica Uddin; Morris Goodman; Offer Erez; Roberto Romero; Guozhen Liu; Munirul Islam; Juan C Opazo; Chet C Sherwood; Lawrence I Grossman; Derek E Wildman
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-27       Impact factor: 11.205

7.  Ancient origin of placental expression in the growth hormone genes of anthropoid primates.

Authors:  Zack Papper; Natalie M Jameson; Roberto Romero; Amy L Weckle; Pooja Mittal; Kurt Benirschke; Joaquin Santolaya-Forgas; Monica Uddin; David Haig; Morris Goodman; Derek E Wildman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-18       Impact factor: 11.205

8.  Maternal psychosocial stress during pregnancy and placenta weight: evidence from a national cohort study.

Authors:  Marion Tegethoff; Naomi Greene; Jørn Olsen; Andrea H Meyer; Gunther Meinlschmidt
Journal:  PLoS One       Date:  2010-12-31       Impact factor: 3.240

9.  Maternal and fetal placental growth hormone and IGF axis in type 1 diabetic pregnancy.

Authors:  Mary F Higgins; Noirin E Russell; Paul A Crossey; Kristine C Nyhan; Derek P Brazil; Fionnuala M McAuliffe
Journal:  PLoS One       Date:  2012-02-17       Impact factor: 3.240

10.  Differential placental expression profile of human Growth Hormone/Chorionic Somatomammotropin genes in pregnancies with pre-eclampsia and gestational diabetes mellitus.

Authors:  Jaana Männik; Pille Vaas; Kristiina Rull; Pille Teesalu; Maris Laan
Journal:  Mol Cell Endocrinol       Date:  2012-02-22       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.